Daniel Elenius Madsen
Leo Pharma (Denmark)(DK)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Dermatology and Skin Diseases, Contact Dermatitis and Allergies, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice(2021)76 cited
- → Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years(2024)46 cited
- → Intraoperative Blood Loss During Orthognathic Surgery Is Predicted by Thromboelastography(2012)26 cited
- → Three months of strictly controlled daily endurance exercise reduces thrombin generation and fibrinolytic risk markers in younger moderately overweight men(2015)22 cited
- → Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema(2014)21 cited
- → C1-inhibitor polymers activate the FXII-dependent kallikrein–kinin system: Implication for a role in hereditary angioedema(2015)19 cited
- → ELISA for determination of total coagulation factor XII concentration in human plasma(2013)19 cited
- → Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema(2025)10 cited
- → Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment(2025)9 cited
- → Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test – Demonstrated in vitro and ex vivo(2017)4 cited